MoonLake Immunotherapeutics (MLTX)

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $1.29 billion. The enterprise value is $986.40 million.

Market Cap	1.29B
Enterprise Value	986.40M

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026, before market open.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

MLTX has 71.37 million shares outstanding. The number of shares has increased by 1.82% in one year.

Current Share Class	71.37M
Shares Outstanding	71.37M
Shares Change (YoY)	+1.82%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	10.56%
Owned by Institutions (%)	27.73%
Float	39.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.99
P/TBV Ratio	4.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.50, with a Debt / Equity ratio of 0.26.

Current Ratio	8.50
Quick Ratio	7.95
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-43.62

Financial Efficiency

Return on equity (ROE) is -54.33% and return on invested capital (ROIC) is -33.09%.

Return on Equity (ROE)	-54.33%
Return on Assets (ROA)	-30.72%
Return on Invested Capital (ROIC)	-33.09%
Return on Capital Employed (ROCE)	-62.63%
Revenue Per Employee	n/a
Profits Per Employee	-$2.10M
Employee Count	100
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MLTX has paid $404,199 in taxes.

Income Tax	404,199
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.94% in the last 52 weeks. The beta is 1.21, so MLTX's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-60.94%
50-Day Moving Average	13.12
200-Day Moving Average	34.16
Relative Strength Index (RSI)	68.68
Average Volume (20 Days)	3,427,381

Short Selling Information

The latest short interest is 4.89 million, so 6.86% of the outstanding shares have been sold short.

Short Interest	4.89M
Short Previous Month	4.27M
Short % of Shares Out	6.86%
Short % of Float	12.40%
Short Ratio (days to cover)	2.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-229.20M
Pretax Income	-213.29M
Net Income	-210.50M
EBITDA	-226.97M
EBIT	-229.20M
Earnings Per Share (EPS)	-$3.33

Balance Sheet

The company has $380.48 million in cash and $75.73 million in debt, with a net cash position of $304.75 million or $4.27 per share.

Cash & Cash Equivalents	380.48M
Total Debt	75.73M
Net Cash	304.75M
Net Cash Per Share	$4.27
Equity (Book Value)	291.19M
Book Value Per Share	4.54
Working Capital	362.85M

Cash Flow

In the last 12 months, operating cash flow was -$185.69 million and capital expenditures -$210,520, giving a free cash flow of -$185.90 million.

Operating Cash Flow	-185.69M
Capital Expenditures	-210,520
Free Cash Flow	-185.90M
FCF Per Share	-$2.60

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.82%
Shareholder Yield	-1.82%
Earnings Yield	-16.30%
FCF Yield	-14.40%

Analyst Forecast

The average price target for MLTX is $30.22, which is 67.05% higher than the current price. The consensus rating is "Buy".

Price Target	$30.22
Price Target Difference	67.05%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1